Insiders At TransMedics Group Sold US$3.7m In Stock, Alluding To Potential Weakness
Insiders At TransMedics Group Sold US$3.7m In Stock, Alluding To Potential Weakness
In the last year, many TransMedics Group, Inc. (NASDAQ:TMDX) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.
去年，許多TransMedics集團公司（納斯達克股票代碼：TMDX）內部人士出售了該公司的大量股份，這可能引起了股東的關注。在分析內幕交易時，了解內部人士是否在買入通常比知道他們是否在賣出更有價值，因爲後者發出的信息模棱兩可。但是，當多個內部人士在特定期限內出售股票時，股東應注意，因爲這可能是一個危險信號。
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
儘管在長期投資方面，內幕交易並不是最重要的事情，但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。
The Last 12 Months Of Insider Transactions At TransMedics Group
TransMedics 集團過去 12 個月的內幕交易
In fact, the recent sale by Waleed Hassanein was the biggest sale of TransMedics Group shares made by an insider individual in the last twelve months, according to our records. So it's clear an insider wanted to take some cash off the table, even below the current price of US$129. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. This single sale was just 2.6% of Waleed Hassanein's stake.
實際上，根據我們的記錄，瓦利德·哈薩內因最近的出售是內部人士在過去十二個月中最大的一次出售TransMedics集團股票。因此，很明顯，一位內部人士想從桌上拿出一些現金，甚至低於目前的129美元價格。當內部人士以低於當前價格的價格出售時，這表明他們認爲較低的價格是公平的。這讓我們想知道他們如何看待最近（更高的）估值。但是，儘管內幕銷售有時令人沮喪，但這只是一個微弱的信號。此次出售僅佔瓦利德·哈薩內因股份的2.6％。
In total, TransMedics Group insiders sold more than they bought over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
總的來說，TransMedics集團內部人士的銷售量超過了去年的買入量。下圖顯示了去年的內幕交易（公司和個人）。如果你想確切地知道誰賣了、賣了多少以及何時出售，只需點擊下圖！
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).
如果你喜歡買內部人士買入而不是賣出的股票，那麼你可能會喜歡這份免費的公司名單。（提示：業內人士一直在購買它們）。
Insiders At TransMedics Group Have Sold Stock Recently
TransMedics集團的內部人士最近出售了股票
The last three months saw significant insider selling at TransMedics Group. In total, insiders dumped US$2.2m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.
在過去的三個月中，TransMedics集團出現了大量的內幕拋售。在此期間，內部人士總共拋售了價值220萬美元的股票，我們沒有記錄任何購買記錄。這可能表明一些內部人士認爲股票並不便宜。
Insider Ownership Of TransMedics Group
TransMedics 集團的內部所有權
Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. TransMedics Group insiders own about US$135m worth of shares (which is 3.2% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
許多投資者喜歡查看公司內部人士擁有多少股份。通常，內部人士的所有權越高，內部人士長期建立公司的可能性就越大。TransMedics集團內部人士擁有價值約1.35億美元的股份（佔該公司的3.2％）。內部人士的這種重要所有權通常會增加公司爲所有股東的利益而經營的機會。
What Might The Insider Transactions At TransMedics Group Tell Us?
TransMedics集團的內幕交易能告訴我們什麼？
Insiders sold stock recently, but they haven't been buying. And our longer term analysis of insider transactions didn't bring confidence, either. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we found 2 warning signs for TransMedics Group that deserve your attention before buying any shares.
內部人士最近出售了股票，但他們一直沒有買入。而且，我們對內幕交易的長期分析也沒有帶來信心。儘管內部人士確實擁有該公司的大量股份（這很好），但我們對他們交易的分析並不能使我們對公司充滿信心。雖然我們喜歡了解內部人士的所有權和交易情況，但在做出任何投資決策之前，我們一定要考慮股票面臨的風險。在Simply Wall St，我們發現了TransMedics集團的兩個警告信號，在購買任何股票之前，值得你注意。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言，內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益，不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎？對內容感到擔憂？直接聯繫我們。 或者，給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論，我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議，也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意，我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之，華爾街沒有持有任何上述股票的頭寸。
譯文內容由第三人軟體翻譯。